Harry Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Richard L. Cassin Editor at Large

Elizabeth K. Spahn Editor Emeritus 

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor

FCPA Blog Daily News

Entries in Parallel Investigations (4)


Free webinar from the Ethical Alliance: What are the odds of getting caught?

A free webinar is currently available to the public from the Ethical Alliance.

Click to read more ...


Could Muddy Waters face charges under China’s criminal law?

After a recent report by Muddy Waters Research called NQ Mobile “A 'Massive Fraud' Worth $0,” the Chinese target fought back, saying Muddy Waters’ accusations were out of the question.

Click to read more ...


SEC’s New Admission Policy: What it Means for FCPA Cases

In 2012, the SEC announced that it would no longer enter into “neither admit nor deny” settlements with companies or individuals who had admitted relevant facts in parallel DOJ dispositions. Since then, the SEC has made good on that promise by requiring such factual admissions in resolving FCPA cases, but only to the extent covered by the DOJ pleadings -- implicitly leaving other allegations under the usual neither admit nor deny approach.

Click to read more ...


Pharma bribe probe points to China parallel prosecutions

Last week, Chinese police detained employees at the Shanghai, Beijing, and Changsha offices of a British pharmaceutical giant as part of an investigation into possible economic crimes committed by the company in China, including bribery.

Click to read more ...